Author

Behzad Hatami

Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and - Cited by 584 - Gastroenterology and Hepatology

Biography

Dr Behzad Hatam is a Senior Researcher of Hepatology at the Research Center for Gastroenterology and Liver Diseases, Tehran, Iran. He is being a Reviewer for Gastrointestinal and Hepatology from Bed to Bench Journal. He is in the Gastroenterology & Hepatology Fellowship program at Shahid Beheshti Medical University, Tehran, Iran from 2013-2015.
Title
Cited by
Year
Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
S Saadati, A Sadeghi, A Mansour, Z Yari, H Poustchi, M Hedayati, ...BMC gastroenterology 19 (1), 1-6, 2019201
96
2019
Antimicrobial resistance as a hidden menace lurking behind the COVID-19 outbreak: the global impacts of too much hygiene on AMR
S Rezasoltani, A Yadegar, B Hatami, H Asadzadeh Aghdaei, MR ZaliFrontiers in microbiology 11, 590683, 2020202
67
2020
The influence of fasting and energy-restricted diets on leptin and adiponectin levels in humans: a systematic review and meta-analysis
HV Kord, GM Tinsley, HO Santos, H Zand, A Nazary, S Fatahi, Z Mokhtari, ...Clinical Nutrition 40 (4), 1811-1821, 2021202
33
2021
Adeno-associated virus as a gene therapy vector: strategies to neutralize the neutralizing antibodies
M Lotfinia, M Abdollahpour-Alitappeh, B Hatami, MR Zali, M KarimipoorClinical and Experimental Medicine 19, 289-298, 2019201
24
2019
Effects of a low free sugar diet on the management of nonalcoholic fatty liver disease: a randomized clinical trial
B Khodami, B Hatami, Z Yari, SM Alavian, A Sadeghi, HK Varkaneh, ...European Journal of Clinical Nutrition 76 (7), 987-994, 2022202
18
2022
How patients with chronic liver diseases succeed to deal with COVID-19?
S Rezasoltani, B Hatami, A Yadegar, H Asadzadeh Aghdaei, MR ZaliFrontiers in Medicine 7, 398, 2020202
14
2020
Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis
S Mazhari, A Gitiara, K Baghaei, B Hatami, RE Rad, A Asadirad, ...European Journal of Pharmacology 882, 173263, 2020202
13
2020
Glutamine powder-induced hepatotoxicity: it is time to understand the side effects of sports nutritional supplements
B Hatami, A Saffaei, F Jamali, M AbbasinazariGastroenterology and Hepatology from Bed to Bench 13 (1), 6, 2020202
8
2020
Presentation of COVID-19 in a liver transplant recipient
B Hatami, PK Moghadam, MR ZaliGastroenterology and Hepatology from Bed to Bench, 2020202
7
2020
Association between Blastocystis and body mass index in healthy subjects; a theoretical pilot study
H Mirjalali, A Latifi, A Taghipour, A Yadegar, B Hatami, A Sadeghi, ...Journal of Diabetes & Metabolic Disorders 19, 129-134, 2020202
7
2020
Dietary and lifestyle inflammation scores are inversely associated with metabolic-associated fatty liver disease among Iranian adults: a nested case-control study
E Taheri, RM Bostick, B Hatami, MA Pourhoseingholi, ...The Journal of Nutrition 12 (2), 9-67, 2022202
5
2022
The triglyceride-glucose index as a clinical useful marker for metabolic associated fatty liver disease (MAFLD): A population-based study among Iranian adults
E Taheri, MA Pourhoseingholi, A Moslem, AH Hassani, A Mousavi Jarrahi, ...Journal of Diabetes & Metabolic Disorders, 1-11, 2022202
5
2022
Does melatonin addition to indomethacin decrease post endoscopic retrograde cholangiopancreatography pancreatitis? A randomized double-blind controlled trial
A Sadeghi, M Abbasinazari, HA Aghdaei, S Abdi, B Hatami, ...European Journal of Gastroenterology & Hepatology 31 (11), 130-13, 2019201
5
2019
Predictors of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Population-Based Study in Northeastern Iran
E Taheri, A Moslem, A Mousavi-jarrahi, B Hatami, MA Pourhosseingholi, ...Gastroenterology and Hepatology from Bed to Bench, 2021202
5
2021
Performance of machine learning techniques on prediction of esophageal varices grades among patients with cirrhosis
A Bayani, F Asadi, A Hosseini, B Hatami, K Kavousi, M Aria, MR ZaliClinical Chemistry and Laboratory Medicine (CCLM) 60 (12), 19-1962, 2022202
5
2022
Identifying predictors of varices grading in patients with cirrhosis using ensemble learning
A Bayani, A Hosseini, F Asadi, B Hatami, K Kavousi, M Aria, MR ZaliClinical Chemistry and Laboratory Medicine (CCLM) 60 (12), 1938-195, 2022202
4
2022
Machine learning-based system for prediction of ascites grades in patients with liver cirrhosis using laboratory and clinical data: design and implementation study
B Hatami, F Asadi, A Bayani, MR Zali, K KavousiClinical Chemistry and Laboratory Medicine (CCLM) 60 (12), 196-195, 2022202
4
2022
Fenofibrate in primary sclerosing cholangitis; a randomized, double‐blind, placebo‐controlled trial
B Hatami, M Mosala, AH Hassani, MJE Ardakani, S Gholami, MR ZaliPharmacology Research & Perspectives 10 (4), e00984, 2022202
3
2022
A case series of variable manifestations of COVID-19 in liver transplant recipients
B Hatami, A Rabbani, PK Moghadam, M Rajabnia, H BorhanyMiddle East Journal of Digestive Diseases 13 (4), 363, 010
2
2021
Mesenchymal stem cells foster Ly-6C low macrophages polarization through the CX3CL1 pathway to ameliorate liver fibrosis
K Baghaei, P Varjavand, A Malmir, S Mazhari, S Tokhanbigli, B Hatami, ...Cytotherapy (5), S67, 000
2
2020

Referred From: https://scholar.google.com/citations?user=OW5re14AAAAJ&hl=en

Cited by
Citations 584
h-index 12
i10-index 14
Recommended Journals
Open Access Journals